Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05106374 · ClinicalTrials.gov registry record

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

A clinical trial of Hematopoietic and Lymphoid Cell Neoplasm and Lung Non-Small Cell Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
182
Enrollment target
1
Study location

NCT05106374 is a study of Hematopoietic and Lymphoid Cell Neoplasm and Lung Non-Small Cell Carcinoma that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 182 participants, below the 951-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05106374, a study of Hematopoietic and Lymphoid Cell Neoplasm and Lung Non-Small Cell Carcinoma, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
182 participants
Enrollment target
1
Study location

Study Summary

This trial evaluates the risk of chemotherapy toxicity in older patients with blood cancer or non-small cell lung cancer. The purpose of this study is to describe a patient's wellness before and after chemotherapy treatment. This may help researchers better understand patient's ability to tolerate treatment and in the future devise the best treatment for a patient based on their "fitness."

Conditions Studied

Hematopoietic and Lymphoid Cell Neoplasm Lung Non-Small Cell Carcinoma

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • PROCEDURE Cognitive Assessment
  • OTHER Physical Performance Testing

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2018-09-04
Est. Completion 2025-12-31

Sponsor

Ohio State University Comprehensive Cancer Center

341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05106374

The ClinicalTrials.gov registry entry for NCT05106374 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 951-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (81% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hematopoietic and Lymphoid Cell Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT05106374 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05106374 about?

NCT05106374 is a clinical study titled "Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer". This trial evaluates the risk of chemotherapy toxicity in older patients with blood cancer or non-small cell lung cancer. The purpose of this study is to describe a patient's wellness before and after chemotherapy treatment. This may help researchers better understand patient's ability to tolerate t...

What is the current status of trial NCT05106374?

This trial is currently active not recruiting. The enrollment target is 182 participants. The study started on 2018-09-04. Estimated completion is 2025-12-31.

What conditions does trial NCT05106374 study?

This clinical trial studies the following conditions: Hematopoietic and Lymphoid Cell Neoplasm, Lung Non-Small Cell Carcinoma.

What interventions are being tested in trial NCT05106374?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Cognitive Assessment (PROCEDURE), Physical Performance Testing (OTHER).

Who is sponsoring clinical trial NCT05106374?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05106374 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hematopoietic and Lymphoid Cell Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hematopoietic and Lymphoid Cell Neoplasm

All registered trials for this condition

Lung Non-Small Cell Carcinoma

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.